EMA Q&A on OOS batches in ATMPs emphasises the importance of digital QMS processes
The EMA's current Q&A on handling Out-Of-Specification (OOS) batches in Advanced Therapy Medicinal Products highlights the stringent requirements for documentation and traceability in this field. If an OOS result occurs,…